Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This is a feasibility study aiming to generate pilot data on safety and efficacy of a novel
anticoagulant regimen (enoxaparin bolus and prolonged infusion) compared to the local
standard-of-care in opiate-treated patients undergoing primary percutaneous coronary
intervention.